These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38786003)
1. PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis. Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003 [TBL] [Abstract][Full Text] [Related]
2. Quercetin induces ferroptosis by inactivating mTOR/S6KP70 pathway in oral squamous cell carcinoma. Zhu YW; Liu CL; Li XM; Shang Y Toxicol Mech Methods; 2024 Jul; 34(6):669-675. PubMed ID: 38736312 [TBL] [Abstract][Full Text] [Related]
3. Effect and mechanism of resveratrol on ferroptosis mediated by p53/SLC7A11 in oral squamous cell carcinoma. Mao C; Gong L; Kang W BMC Oral Health; 2024 Jul; 24(1):773. PubMed ID: 38987730 [TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11. Liang B; Wu Y Arch Oral Biol; 2023 Dec; 156():105807. PubMed ID: 37776596 [TBL] [Abstract][Full Text] [Related]
5. Astaxanthin Synergizes with Ionizing Radiation (IR) in Oral Squamous Cell Carcinoma (OSCC). Du Y; Shuai Y; Liu Z; Li H; Yin Y Mol Biotechnol; 2024 May; 66(5):1220-1228. PubMed ID: 38103098 [TBL] [Abstract][Full Text] [Related]
6. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway. Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316 [TBL] [Abstract][Full Text] [Related]
7. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma. Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976 [TBL] [Abstract][Full Text] [Related]
8. MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11. Sun K; Ren W; Li S; Zheng J; Huang Y; Zhi K; Gao L Pathol Res Pract; 2022 Mar; 231():153778. PubMed ID: 35093695 [TBL] [Abstract][Full Text] [Related]
9. NFE2L1 restrains ferroptosis by transcriptionally regulating HJURP and participates in the progress of oral squamous cell carcinoma. Zhang M; Wang Z; Yang G; Han L; Wang X J Bioenerg Biomembr; 2023 Dec; 55(6):467-478. PubMed ID: 37848756 [TBL] [Abstract][Full Text] [Related]
10. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma. Wang Z; Tang S; Cai L; Wang Q; Pan D; Dong Y; Zhou H; Li J; Ji N; Zeng X; Zhou Y; Shen YQ; Chen Q Br J Cancer; 2024 May; 130(11):1744-1757. PubMed ID: 38582810 [TBL] [Abstract][Full Text] [Related]
11. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway. Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026 [TBL] [Abstract][Full Text] [Related]